McMaster University has received funding from Cambrian Biosciences, Catalym, Espervita Therapeutics, Esperion Therapeutics, Poxel Pharmaceuticals, Merck, Nestle, and Novo Nordisk for research conducted in the laboratory of G.R.S
Recent studies from 2025 have shown that tirzepatide demonstrates superior weight loss results compared to semaglutide in head-to-head comparisons
But whats kept me here is the ability to help people transform their lives in a way that feels both meaningful and lasting
The body heavily relies on mitochondrial uncoupling to dissipate this energy, preventing those fatty acids from just moving to different fat cells
Semaglutide has more GI side effects because it is stronger, so it's important to be careful when you dose it
doi: 10.17305/bjbms.2021.6299 10 XuRWangFZhangZZhangYTangYBiJet al